Pharmaceutical & Healthcare

Pharmaceutical & Healthcare

The global pharmaceutical market was worth $996bn in 2017, up almost 3% on the year before. The US accounted for 45% of that total, or $453bn. Europe contributed a further 21% (or $214bn), and the rest of the established world for 11% (or $112bn). The fastest growth continues to come from emerging markets, where sales rose by almost 8% in 2017 to $216bn. The top five markets by value are the US, Japan, China, Germany and France. Drug development has slowed dramatically as a result of rising costs. Despite a total R&D budget of $154bn in 2016, only 22 new drugs were approved by the US FDA in 2016, fewer than half the year before.

The World's Leading Pharma Companies in 2017 by healthcare revenues

 Johnson & Johnson  Gilead Sciences
 Roche  Eli Lilly & Co
 Pfizer  Amgen
 Novartis  AstraZeneca
 Merck & Co  Teva
 Sanofi  Bristol-Myers Squibb
 Glaxo SmithKline  Boehringer Ingelheim
 AbbVie Novo Nordisk
 Bayer  Takeda
 Abbott Laboratories  Allergan

Source: company reports

The World's Top 20 Prescription Drugs in 2017 by global sales

Humira $18.43bn AbbVie Januvia / Janumet $5.90bn Merck
Eylea $8.23bn Bayer / Regeneron Lantus $5.65bn Sanofi
Revlimid $8.19bn Celgene Prevnar $5.60bn Pfizer
Rituxan / MabThera $8.11bn Roche Opdivo $4.95bn BMS
Enbrel $7.98bn Amgen / Pfizer / Takeda Neulasta / Peglasta $4.56bn Amgen
Herceptin $7.55bn Roche Lyrica $4.51bn Pfizer / Eisai
Eliquis $7.40bn BMS / Pfizer Harvoni $4.37bn Gilead Sciences
Avastin $7.21bn Roche Seretide / Advair $4.36bn GlaxoSmithKline
Remicade $7.16bn J&J / Merck / Mitsubishi Tanabe Tecfidera $5.23bn Biogen
Xarelto $6.54bn Bayer/ J&J Stelara $4.01bn J&J

Source: Igea, company reports

The World's Top Consumer Health Companies in 2017

 Johnson & Johnson $13.6bn  Reckitt Benckiser $6.9bn
 GlaxoSmithKline $10.5bn  Sanofi $4.8bn
 Amway $8.6bn  Herbalife $4.4bn
 Procter & Gamble $7.5bn  Pfizer $3.5bn
 Bayer $7.0bn  Nature's Bounty $3.3bn

Source: Igea, company reports; includes skincare, personal care, oral care, nutritionals, vitamins & hygiene

The World's Top Animal Healthcare Companies in 2014

 Zoetis (ex-Pfizer) 20% global share  Merial (Sanofi) 12%
 Elanco/Novartis AH (Eli Lilly & Co) 15%  Bayer 7%
 Merck & Co 14%  Boehringer Ingelheim 6%

Source: PwC

Top US OTC Products in 2013 by sales

Advil (Pfizer) $615m Alcon (Novartis) $447m Dr Scholl's (Merck*) $370m
Nature Made $596m Claritin (Merck*) $430m Aleve (Bayer) $364m
Mucinex (Reckitt) $578m Depend (Kimberly-Clark) $393m Prilosec OTC (P&G) $359m
Ensure (Abbott) $496m Poise (Kimberly-Clark) $379m 5 Hour Energy $332m

* Bayer from 2014. Source: Main products including biggest variants; IRI 52 wks to Jan 2014 all channels, Drugstorenews

Other companies profiled in Adbrands

 Bausch Health (formerly Valeant)  Astellas Pharma

Gone But Not (Completely) Forgotten

 Warner-Lambert  Smithkline Beecham
 Wyeth  Aventis
 Schering-Plough  Pharmacia

All rights reserved © Mind Advertising Ltd 1998-2019